Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins in atherothrombosis.

Susanna Colli1, José Pablo Werba, Elena Tremoli

  • 1E. Grossi Paoletti Center, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy.

Seminars in Vascular Medicine
|April 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of in-hospital atrial fibrillation after acute myocardial infarction: a cross-cohort study in Italian and Finnish patients.

International journal of medical informatics·2026
Same author

Multifactorial strategies for the prevention of the risks of ulceration in patients affected by diabetic foot: a no-profit, multicentre, clinical trial protocol.

BMJ open·2026
Same author

Novel mechanisms linking platelet activation to antiphospholipid syndrome.

Current opinion in immunology·2026
Same author

Correlation between frailty status, surgical access, and outcomes in older adults with valvular heart disease undergoing cardiac surgery.

npj aging·2026
Same author

Impact of green tea on pharmacokinetics in cardiovascular therapy: current insights.

Expert opinion on drug metabolism & toxicology·2026
Same author

Mitochondrial permeability transition pore desensitization by a novel dispiranic derivative prevents cardiac reperfusion injury.

Redox biology·2026

Statins (hydroxy-methyl glutaryl coenzyme A reductase inhibitors) offer significant antithrombotic effects, reducing vascular events. Their mechanisms involve inhibiting thrombin generation, independent of cholesterol-lowering, by affecting isoprenoid biosynthesis.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Thrombosis Research

Background:

  • Hydroxy-methyl glutaryl coenzyme A reductase inhibitors (statins) are known for cholesterol-lowering effects.
  • Clinical evidence suggests statins favorably impact atherothrombosis and reduce vascular events.

Purpose of the Study:

  • To investigate the antithrombotic mechanisms of statins.
  • To elucidate the pathways through which statins inhibit thrombosis and affect vascular events.

Main Methods:

  • Review of clinical studies and in vitro/in vivo data on statin effects.
  • Analysis of statin's influence on platelet activation, fibrinolysis, and coagulation factors.
  • Investigation of thrombin generation pathways, including the tissue factor/factor VII pathway.

Related Experiment Videos

Main Results:

  • Statins reduce atheroma progression and the incidence of thrombosis-related vascular events.
  • Statins exhibit antithrombotic effects, particularly in high-risk patients.
  • In vitro data suggest statins inhibit thrombin generation via tissue factor/factor VII, independent of cholesterol lowering, through isoprenoid biosynthesis inhibition.

Conclusions:

  • Statins possess significant antithrombotic properties beyond lipid lowering.
  • The primary antithrombotic mechanism appears to involve the inhibition of isoprenoid biosynthesis, affecting thrombin generation.
  • Further clinical research is needed to establish the precise contribution of prenylated proteins and cholesterol pathways to statin's effects on tissue factor expression.